A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts

Endocrinology. 1991 Oct;129(4):1762-8. doi: 10.1210/endo-129-4-1762.

Abstract

PTH-related protein (PTHrP) interacts, via its amino-terminal 34 residues, with PTH receptors on osteoblasts to stimulate osteoclastic bone resorption indirectly. We now report that mature hPTHrP-(1-141) (EC50, approximately 10(-11) M) and a carboxyl-terminal fragment, PTHrP-(107-139) (EC50, approximately 10(-15) M), are potent inhibitors of resorption in an isolated rat osteoclast bone resorption assay, whereas hPTHrP-(1-108) and hPTHrP-(1-34) are inactive in this respect. PTHrP-(107-139) also inhibits resorption in a rat long bone organ culture system and reduces osteoclast spreading. PTHrP-(107-139) does not act on osteoclasts via a cAMP signal transduction mechanism, but its effects may be mediated by protein kinase-C. This previously unrecognized action of PTHrP, to inhibit osteoclastic bone resorption directly, indicates that PTHrP may be a precursor of multiple biologically active peptides with differing physiological functions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Bone Resorption*
  • Cells, Cultured
  • Cytological Techniques
  • Cytoplasm / ultrastructure
  • Molecular Sequence Data
  • Osteoclasts / drug effects
  • Osteoclasts / physiology*
  • Osteoclasts / ultrastructure
  • Parathyroid Hormone-Related Protein*
  • Peptide Fragments / pharmacology*
  • Proteins / pharmacology*
  • Signal Transduction
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Parathyroid Hormone-Related Protein
  • Peptide Fragments
  • Proteins
  • parathyroid hormone-related protein (107-139)